References 139 45. Barber M, Brubaker L, Nygaard I, et al. Defining “success” after surgery for pelvic organ prolapse. Neurourol Urodyn 2009;28:590-1. 46. FDA. FDA warns against use of energy-based devices to perform vaginal rejuvenation or vaginal cosmetic procedures: FDA safety communication. Date Issued: July 30, 2018. https://www.fda.gov/ medical-devices/safety-communications/fda-warns-against-useenergy-baseddevices-perform-vaginal-rejuvenation-or-vaginalcosmetic. 2018: . 47. Bhide AA, Khullar V, Swift S, Digesu GA. The use of laser in urogynaecology. Int Urogynecol J 2019;30:683-92. 48. Hillard TC. Lasers in the era of evidence-based medicine. Climacteric 2020;23:S6-S10. 49. Giarenis I, Tsiapakidou S, Zacche M, Mukhopadhyay S, Mahmood T. European Board and College of Obstetrics and Gynaecology (EBCOG) position statement on the use of laser vaginal devices for treatment of genitourinary syndrome of menopause, vaginal laxity, pelvic organ prolapse and stress urinary incontinence. Eur J Obstet Gynecol Reprod Biol 2024. 50. Zhang C, Chen Y, Liu S, Chen J, Shen H, Luo D. Effect of vaginal energy-based treatment on female stress urinary incontinence: a systematic review and meta-analysis of randomized controlled trials. World J Urol 2023;41:405-11. 51. Mackova K, Van daele L, Page A-S, Geraerts I, Krofta L, Deprest J. Laser therapy for urinary incontinence and pelvic organ prolapse: a systematic review. BJOG 2020;127:1338-46. 52. Persu C, Chapple CR, Cauni V, Gutue S, Geavlete P. Pelvic Organ Prolapse Quantification System (POP-Q) - a new era in pelvic prolapse staging. J Med Life 2011;4:75-81. 53. DELANCEY JOL. Anatomy and Biomechanics of Genital Prolapse. Clin Obstet Gynecol 1993;36:897-909. 54. Vizintin Z, Lukac M, Kazic M, Tettamanti M. Erbium laser in gynecology. Climacteric 2015;18:48. 55. Pardo JI, Solà VR, Morales AA. Treatment of female stress urinary incontinence with ErbiumYAG laser in non-ablative mode. Eur J Obstet Gynecol Reprod Biol 2016;204:1-4. 56. Fistonić N, Fistonić I, Guštek Š F, et al. Minimally invasive, non-ablative Er:YAG laser treatment of stress urinary incontinence in women--a pilot study. Lasers Med Sci 2016;31:635-43. 57. Ogrinc U, Sencar S. Non-ablative vaginal erbium YAG laser for the treatment of cystocele. Ital J Gynaecol Obstet 2017;29:19-25. 58. Athanasiou S, Pitsouni E, Cardozo L, et al. Can pelvic organ prolapse in postmenopausal women be treated with laser therapy? Climacteric 2021;24:101-6. 59. Novakov Mikic A. LBB, Hreljac I.,Vižintin Z. . Non-ablative vaginal erbium laser treatment of patients with cystocele and stress urinary incontinence – a retrospective study. EGO European Gynecology and Obstetrics 2023;01:004-9. 60. Teleman P, Stenzelius K, Iorizzo L, Jakobsson U. Validation of the Swedish short forms of the Pelvic Floor Impact Questionnaire (PFIQ-7), Pelvic Floor Distress Inventory (PFDI-20) and Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12). Acta Obstet Gynecol Scand 2011;90:483-7. 61. Abrams P, Andersson K-E, Apostolidis A, et al. 6th International Consultation on Incontinence. Recommendations of the International Scientific Committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence. Neurourol Urodyn 2018;37:2271-2. 62. Karjalainen PK, Mattsson NK, Jalkanen JT, Nieminen K, Tolppanen AM. Minimal important difference and patient acceptable symptom state for PFDI-20 and POPDI-6 in POP surgery. Int Urogynecol J 2021;32:3169-76. 63. Wiegersma M, Panman CM, Kollen BJ, et al. Pelvic floor muscle training versus watchful waiting or pessary treatment for pelvic organ prolapse (POPPS): design and participant baseline characteristics of two parallel pragmatic randomized controlled trials in primary care. Maturitas 2014;77:168-73. 64. Srikrishna S, Robinson D, Cardozo L. Validation of the Patient Global Impression of Improvement (PGI-I) for urogenital prolapse. Int Urogynecol J 2010;21:523-8. 65. Rogers RG, Espuña Pons ME. The Pelvic Organ Prolapse Incontinence Sexual Questionnaire, IUGA-revised (PISQ-IR). Int Urogynecol J 2013;24:1063-4. 66. Shumaker SA, Wyman JF, Uebersax JS, McClish D, Fantl JA. Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group. Qual Life Res 1994;3:291-306.
RkJQdWJsaXNoZXIy MTk4NDMw